These treatments can modify or bolster the bodys immune response, restore balance, and reduce the side effects commonly associated with oral medications, such as gastrointestinal discomfort
When used long-term, tesamorelin is primarily beneficial for reducing visceral fat but may require ongoing use to maintain results, as fat accumulation can return after discontinuation
How does this improve my health span
Baseline labs before starting GHK-Cu alongside rosuvastatin: Creatine kinase (CK) to establish a pre-treatment reference Hepatic panel (ALT, AST, total bilirubin) Serum copper and ceruloplasmin if planning GHK-Cu use beyond 8 weeks 8 Follow-up monitoring: Repeat hepatic panel at 4-6 weeks, consistent with the 2018 ACC/AHA cholesterol guideline recommendations for statin therapy 12 CK measurement only if the patient develops muscle pain, tenderness, or weakness (routine CK screening is not recommended per the same guideline) Serum copper at 12 weeks for subcutaneous GHK-Cu users
Most clients receive injections weekly to monthly, depending on their goals and lab results
C.ChanS